Index by author
November 01, 2003; Volume 31,Issue 11
A
Arison, Byron H.
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
Assang, Carol
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
B
Baillie, Thomas A.
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
Benet, Leslie Z.
- You have accessDISPOSITION OF TACROLIMUS IN ISOLATED PERFUSED RAT LIVER: INFLUENCE OF TROLEANDOMYCIN, CYCLOSPORINE, AND GG918Chi-Yuan Wu and Leslie Z. BenetDrug Metabolism and Disposition November 2003, 31 (11) 1292-1295; DOI: https://doi.org/10.1124/dmd.31.11.1292
Berry, Loren M.
- You have accessPHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANSChyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. LiuDrug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
Bible, Roy H.
- You have accessPHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANSChyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. LiuDrug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
Braun, Matthew P.
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Byrnes-Blake, Kelly A.
- You have accessUSE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATSElizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael OwensDrug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
C
Cassidy, K. C.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Chappell, Alfred
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Chatterjee, Parnali
- You have accessHUMAN CYTOCHROME P450 INHIBITION AND METABOLIC-INTERMEDIATE COMPLEX FORMATION BY GOLDENSEAL EXTRACT AND ITS METHYLENEDIOXYPHENYL COMPONENTSParnali Chatterjee and Michael R. FranklinDrug Metabolism and Disposition November 2003, 31 (11) 1391-1397; DOI: https://doi.org/10.1124/dmd.31.11.1391
Cherrington, Nathan J.
- You have accessINDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTORNathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
- You have accessCONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATSSupratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337
Choudhuri, Supratim
- You have accessCONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATSSupratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337
Cook, Chyung S.
- You have accessPHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANSChyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. LiuDrug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
Cramer, J. W.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Cui, Donghui
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
Cummins, Len
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
D
Dalvie, Deepak K.
- You have accessMECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFENJohn P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott ObachDrug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369
Duanmu, Zhengbo
- You have accessTRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTIONHai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-MorrisDrug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378
Dunbar, Debbie
- You have accessCHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSIONQing-Yu Zhang, Debbie Dunbar and Laurence S. KaminskyDrug Metabolism and Disposition November 2003, 31 (11) 1346-1351; DOI: https://doi.org/10.1124/dmd.31.11.1346
F
Fang, Hai-Lin
- You have accessTRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTIONHai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-MorrisDrug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378
Farid, N. A.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Franklin, Michael R.
- You have accessHUMAN CYTOCHROME P450 INHIBITION AND METABOLIC-INTERMEDIATE COMPLEX FORMATION BY GOLDENSEAL EXTRACT AND ITS METHYLENEDIOXYPHENYL COMPONENTSParnali Chatterjee and Michael R. FranklinDrug Metabolism and Disposition November 2003, 31 (11) 1391-1397; DOI: https://doi.org/10.1124/dmd.31.11.1391
Fukumoto, Hiroyuki
- You have accessMETABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERSHiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira TsujiDrug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
Fukushima, Yoko
- You have accessMETABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERSHiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira TsujiDrug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
Furuta, Takashi
- You have accessEVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANSTakashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji KasuyaDrug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
G
Gadberry, M. G.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Gasiewicz, Thomas A.
- You have accessTHE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTORAby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. ReinersDrug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279
Geary, Richard S.
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Geer, Leslie A.
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
Geng, Wanping
- You have accessA METHOD FOR IDENTIFICATION OF INHIBITION MECHANISM AND ESTIMATION OF KI IN IN VITRO ENZYME INHIBITION STUDYWanping GengDrug Metabolism and Disposition November 2003, 31 (11) 1456-1457; DOI: https://doi.org/10.1124/dmd.31.11.1456
Gentry, W. Brooks
- You have accessUSE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATSElizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael OwensDrug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
Gibson, Christopher R.
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Greenblatt, David J.
- You have accessTHE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMESJill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. GreenblattDrug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
Grillo, Mark P.
- You have accessSTUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILEMark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. WareDrug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
- You have accessIDENTIFICATION OF ZOMEPIRAC-S-ACYL-GLUTATHIONE IN VITRO IN INCUBATIONS WITH RAT HEPATOCYTES AND IN VIVO IN RAT BILEMark P. Grillo and Fengmei HuaDrug Metabolism and Disposition November 2003, 31 (11) 1429-1436; DOI: https://doi.org/10.1124/dmd.31.11.1429
H
Hajdu, Elisabeth
- You have accessPHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANSChyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. LiuDrug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
Halpin, Rita A.
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
Hardee, Greg E.
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Harmatz, Jerold S.
- You have accessTHE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMESJill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. GreenblattDrug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
Hayakawa, Hiroyoshi
- You have accessMETABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERSHiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira TsujiDrug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
Hazai, Eszter
- You have accessGYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCERViola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin MonostoryDrug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
Henry, Scott P.
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Ho, Jonathan Z.
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Hribar, Jeremy D.
- You have accessPHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANSChyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. LiuDrug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
Hua, Fengmei
- You have accessSTUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILEMark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. WareDrug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
- You have accessIDENTIFICATION OF ZOMEPIRAC-S-ACYL-GLUTATHIONE IN VITRO IN INCUBATIONS WITH RAT HEPATOCYTES AND IN VIVO IN RAT BILEMark P. Grillo and Fengmei HuaDrug Metabolism and Disposition November 2003, 31 (11) 1429-1436; DOI: https://doi.org/10.1124/dmd.31.11.1429
Huang, Wendong
- You have accessINDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTORNathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
I
Ingelman-Sundberg, Magnus
- You have accessGYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCERViola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin MonostoryDrug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
J
Jackson, D. A.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Jekerle, Veronika
- You have accessINDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORSShirley Teng, Veronika Jekerle and Micheline Piquette-MillerDrug Metabolism and Disposition November 2003, 31 (11) 1296-1299; DOI: https://doi.org/10.1124/dmd.31.11.1296
Joiakim, Aby
- You have accessTHE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTORAby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. ReinersDrug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279
K
Kadota, Takumi
- You have accessMETABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERSHiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira TsujiDrug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
Kalgutkar, Amit S.
- You have accessMECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFENJohn P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott ObachDrug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369
Kaminsky, Laurence S.
- You have accessCHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSIONQing-Yu Zhang, Debbie Dunbar and Laurence S. KaminskyDrug Metabolism and Disposition November 2003, 31 (11) 1346-1351; DOI: https://doi.org/10.1124/dmd.31.11.1346
Kasuya, Yasuji
- You have accessEVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANSTakashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji KasuyaDrug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
Kato, Hiroshi
- You have accessMETABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERSHiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira TsujiDrug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
Klaassen, Curtis D.
- You have accessINDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTORNathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
- You have accessCONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATSSupratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337
Knutson, Charles G.
- You have accessSTUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILEMark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. WareDrug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
Kocarek, Thomas A.
- You have accessTRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTIONHai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-MorrisDrug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378
Kuehl, Gwendolyn E.
- You have accessN-GLUCURONIDATION OF NICOTINE AND COTININE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED UDP-GLUCURONOSYLTRANSFERASESGwendolyn E. Kuehl and Sharon E. MurphyDrug Metabolism and Disposition November 2003, 31 (11) 1361-1368; DOI: https://doi.org/10.1124/dmd.31.11.1361
Kuroiwa, Hiroyuki
- You have accessMETABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERSHiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira TsujiDrug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
L
Laurenzana, Elizabeth M.
- You have accessUSE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATSElizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael OwensDrug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
Levin, Arthur A.
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Li, Ning
- You have accessCONSTITUTIVE EXPRESSION OF VARIOUS XENOBIOTIC AND ENDOBIOTIC TRANSPORTER mRNAs IN THE CHOROID PLEXUS OF RATSSupratim Choudhuri, Nathan J. Cherrington, Ning Li and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1337-1345; DOI: https://doi.org/10.1124/dmd.31.11.1337
Lin, Charles C.
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Liu, Norman W.
- You have accessPHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANSChyung S. Cook, Loren M. Berry, Roy H. Bible, Jeremy D. Hribar, Elisabeth Hajdu and Norman W. LiuDrug Metabolism and Disposition November 2003, 31 (11) 1448-1455; DOI: https://doi.org/10.1124/dmd.31.11.1448
Lu, Ping
- You have accessMECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITORPing Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David RodriguesDrug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
M
Ma, Bennett
- You have accessSOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITROBennett Ma, Magang Shou and Michael L. SchragDrug Metabolism and Disposition November 2003, 31 (11) 1300-1305; DOI: https://doi.org/10.1124/dmd.31.11.1300
Maher, Jonathan M.
- You have accessINDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTORNathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
Mathieu, Patricia A.
- You have accessTHE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTORAby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. ReinersDrug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279
Matson, John
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Mattiuz, E. L.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Milesi-Hallé, Alessandra
- You have accessUSE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATSElizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael OwensDrug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
Monostory, Katalin
- You have accessGYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCERViola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin MonostoryDrug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
Moore, David D.
- You have accessINDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTORNathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
Mori, Chieko
- You have accessEVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANSTakashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji KasuyaDrug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
Murphy, Sharon E.
- You have accessN-GLUCURONIDATION OF NICOTINE AND COTININE BY HUMAN LIVER MICROSOMES AND HETEROLOGOUSLY EXPRESSED UDP-GLUCURONOSYLTRANSFERASESGwendolyn E. Kuehl and Sharon E. MurphyDrug Metabolism and Disposition November 2003, 31 (11) 1361-1368; DOI: https://doi.org/10.1124/dmd.31.11.1361
N
Nishigaki, Junko
- You have accessMETABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERSHiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira TsujiDrug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
O
O'Bannon, D. D.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
O'Donnell, John P.
- You have accessMECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFENJohn P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott ObachDrug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369
Obach, R. Scott
- You have accessMECHANISM-BASED INACTIVATION OF HUMAN RECOMBINANT P450 2C9 BY THE NONSTEROIDAL ANTI-INFLAMMATORY DRUG SUPROFENJohn P. O'Donnell, Deepak K. Dalvie, Amit S. Kalgutkar and R. Scott ObachDrug Metabolism and Disposition November 2003, 31 (11) 1369-1377; DOI: https://doi.org/10.1124/dmd.31.11.1369
Owens, S. Michael
- You have accessUSE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATSElizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael OwensDrug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
P
Palermo, Christine
- You have accessTHE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTORAby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. ReinersDrug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279
Perkins, E. J.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Piquette-Miller, Micheline
- You have accessINDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORSShirley Teng, Veronika Jekerle and Micheline Piquette-MillerDrug Metabolism and Disposition November 2003, 31 (11) 1296-1299; DOI: https://doi.org/10.1124/dmd.31.11.1296
Pitzenberger, Steven M.
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Porsmyr-Palmertz, Margareta
- You have accessGYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCERViola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin MonostoryDrug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
R
Raab, Conrad E.
- You have accessMECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITORPing Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David RodriguesDrug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
Reiners, John J.
- You have accessTHE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTORAby Joiakim, Patricia A. Mathieu, Christine Palermo, Thomas A. Gasiewicz and John J. ReinersDrug Metabolism and Disposition November 2003, 31 (11) 1279-1282; DOI: https://doi.org/10.1124/dmd.31.11.1279
Rodrigues, A. David
- You have accessMECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITORPing Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David RodriguesDrug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
Runge-Morris, Melissa
- You have accessTRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTIONHai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-MorrisDrug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378
S
Sanders, Phillip E.
- You have accessSTUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILEMark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. WareDrug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
Sasmor, Henri
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Schrag, Michael L.
- You have accessSOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITROBennett Ma, Magang Shou and Michael L. SchragDrug Metabolism and Disposition November 2003, 31 (11) 1300-1305; DOI: https://doi.org/10.1124/dmd.31.11.1300
- You have accessMECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITORPing Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David RodriguesDrug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
Shader, Richard I.
- You have accessTHE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMESJill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. GreenblattDrug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
Shenoy, Sarita
- You have accessTRANSACTIVATION OF GLUCOCORTICOID-INDUCIBLE RAT ARYL SULFOTRANSFERASE (SULT1A1) GENE TRANSCRIPTIONHai-Lin Fang, Sarita Shenoy, Zhengbo Duanmu, Thomas A. Kocarek and Melissa Runge-MorrisDrug Metabolism and Disposition November 2003, 31 (11) 1378-1381; DOI: https://doi.org/10.1124/dmd.31.11.1378
Shibasaki, Hiromi
- You have accessEVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANSTakashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji KasuyaDrug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
Shou, Magang
- You have accessSOLVENT EFFECT ON cDNA-EXPRESSED HUMAN SULFOTRANSFERASE (SULT) ACTIVITIES IN VITROBennett Ma, Magang Shou and Michael L. SchragDrug Metabolism and Disposition November 2003, 31 (11) 1300-1305; DOI: https://doi.org/10.1124/dmd.31.11.1300
- You have accessMECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITORPing Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David RodriguesDrug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
Silva-Elipe, Maria V.
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Singh, Rominder
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Slaughter, Donald
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
Slaughter, Donald E.
- You have accessMECHANISM-BASED INHIBITION OF HUMAN LIVER MICROSOMAL CYTOCHROME P450 1A2 BY ZILEUTON, A 5-LIPOXYGENASE INHIBITORPing Lu, Michael L. Schrag, Donald E. Slaughter, Conrad E. Raab, Magang Shou and A. David RodriguesDrug Metabolism and Disposition November 2003, 31 (11) 1352-1360; DOI: https://doi.org/10.1124/dmd.31.11.1352
Slitt, Angela L.
- You have accessINDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTORNathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
Subramanian, Raju
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Suzuki, Atsushi
- You have accessEVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANSTakashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji KasuyaDrug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
T
Takenaga, Norihiro
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
Tamási, Viola
- You have accessGYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCERViola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin MonostoryDrug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
Teng, Shirley
- You have accessINDUCTION OF ABCC3 (MRP3) BY PREGNANE X RECEPTOR ACTIVATORSShirley Teng, Veronika Jekerle and Micheline Piquette-MillerDrug Metabolism and Disposition November 2003, 31 (11) 1296-1299; DOI: https://doi.org/10.1124/dmd.31.11.1296
Tsuji, Akira
- You have accessMETABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERSHiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira TsujiDrug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
V
Vereczkey, László
- You have accessGYKI-47261, A NEW AMPA [2-AMINO-3-(3-HYDROXYMETHYLISOXAZOLE-4-YL)PROPIONIC ACID] ANTAGONIST, IS A CYP2E1 INDUCERViola Tamási, Eszter Hazai, Margareta Porsmyr-Palmertz, Magnus Ingelman-Sundberg, László Vereczkey and Katalin MonostoryDrug Metabolism and Disposition November 2003, 31 (11) 1310-1314; DOI: https://doi.org/10.1124/dmd.31.11.1310
Von Moltke, Lisa L.
- You have accessTHE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMESJill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. GreenblattDrug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
Vyas, Kamlesh P.
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
W
Waldon, Daniel J.
- You have accessSTUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILEMark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. WareDrug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
Walle, Thomas
- You have accessTHE β-d-GLUCOSIDE AND SODIUM-DEPENDENT GLUCOSE TRANSPORTER 1 (SGLT1)-INHIBITOR PHLORIDZIN IS TRANSPORTED BY BOTH SGLT1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS 1/2Thomas Walle and U. Kristina WalleDrug Metabolism and Disposition November 2003, 31 (11) 1288-1291; DOI: https://doi.org/10.1124/dmd.31.11.1288
Walle, U. Kristina
- You have accessTHE β-d-GLUCOSIDE AND SODIUM-DEPENDENT GLUCOSE TRANSPORTER 1 (SGLT1)-INHIBITOR PHLORIDZIN IS TRANSPORTED BY BOTH SGLT1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS 1/2Thomas Walle and U. Kristina WalleDrug Metabolism and Disposition November 2003, 31 (11) 1288-1291; DOI: https://doi.org/10.1124/dmd.31.11.1288
Walsh, Deborah J.
- You have accessMETABOLISM OF ROFECOXIB IN VITRO USING HUMAN LIVER SUBCELLULAR FRACTIONSDonald Slaughter, Norihiro Takenaga, Ping Lu, Carol Assang, Deborah J. Walsh, Byron H. Arison, Donghui Cui, Rita A. Halpin, Leslie A. Geer, Kamlesh P. Vyas and Thomas A. BaillieDrug Metabolism and Disposition November 2003, 31 (11) 1398-1408; DOI: https://doi.org/10.1124/dmd.31.11.1398
Wan, Yu-Jui Yvonne
- You have accessINDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTORNathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
Ware, Joseph A.
- You have accessSTUDIES ON THE CHEMICAL REACTIVITY OF DICLOFENAC ACYL GLUCURONIDE WITH GLUTATHIONE: IDENTIFICATION OF DICLOFENAC-S-ACYL-GLUTATHIONE IN RAT BILEMark P. Grillo, Charles G. Knutson, Phillip E. Sanders, Daniel J. Waldon, Fengmei Hua and Joseph A. WareDrug Metabolism and Disposition November 2003, 31 (11) 1327-1336; DOI: https://doi.org/10.1124/dmd.31.11.1327
Warrington, Jill S.
- You have accessTHE EFFECT OF AGE ON SILDENAFIL BIOTRANSFORMATION IN RAT AND MOUSE LIVER MICROSOMESJill S. Warrington, Lisa L. Von Moltke, Jerold S. Harmatz, Richard I. Shader and David J. GreenblattDrug Metabolism and Disposition November 2003, 31 (11) 1306-1309; DOI: https://doi.org/10.1124/dmd.31.11.1306
Watanabe, Tanya
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Weiss, H. J.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Wheeler, W. J.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Williams, D. Keith
- You have accessUSE OF ANTI-(+)-METHAMPHETAMINE MONOCLONAL ANTIBODY TO SIGNIFICANTLY ALTER (+)-METHAMPHETAMINE AND (+)-AMPHETAMINE DISPOSITION IN RATSElizabeth M. Laurenzana, Kelly A. Byrnes-Blake, Alessandra Milesi-Hallé, W. Brooks Gentry, D. Keith Williams and S. Michael OwensDrug Metabolism and Disposition November 2003, 31 (11) 1320-1326; DOI: https://doi.org/10.1124/dmd.31.11.1320
Wood, P. G.
- You have accessPRECLINICAL CHARACTERIZATION OF 2-[3-[3-[(5-ETHYL-4′-FLUORO-2-HYDROXY[1,1′-BIPHENYL]-4-YL)OXY]PROPOXY]-2-PROPYLPHENOXY]BENZOIC ACID METABOLISM: IN VITRO SPECIES COMPARISON AND IN VIVO DISPOSITION IN RATSE. J. Perkins, J. W. Cramer, N. A. Farid, M. G. Gadberry, D. A. Jackson, E. L. Mattiuz, D. D. O'Bannon, H. J. Weiss, W. J. Wheeler, P. G. Wood and K. C. CassidyDrug Metabolism and Disposition November 2003, 31 (11) 1382-1390; DOI: https://doi.org/10.1124/dmd.31.11.1382
Wu, Chi-Yuan
- You have accessDISPOSITION OF TACROLIMUS IN ISOLATED PERFUSED RAT LIVER: INFLUENCE OF TROLEANDOMYCIN, CYCLOSPORINE, AND GG918Chi-Yuan Wu and Leslie Z. BenetDrug Metabolism and Disposition November 2003, 31 (11) 1292-1295; DOI: https://doi.org/10.1124/dmd.31.11.1292
Y
Yamamoto, Hiroyuki
- You have accessMETABOLISM AND DISPOSITION OF NOVEL DES-FLUORO QUINOLONE GARENOXACIN IN EXPERIMENTAL ANIMALS AND AN INTERSPECIES SCALING OF PHARMACOKINETIC PARAMETERSHiroyoshi Hayakawa, Yoko Fukushima, Hiroshi Kato, Hiroyuki Fukumoto, Takumi Kadota, Hiroyuki Yamamoto, Hiroyuki Kuroiwa, Junko Nishigaki and Akira TsujiDrug Metabolism and Disposition November 2003, 31 (11) 1409-1418; DOI: https://doi.org/10.1124/dmd.31.11.1409
Yergey, James L.
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Yokokawa, Akitomo
- You have accessEVIDENCE FOR THE VALIDITY OF CORTISOL 6β-HYDROXYLATION CLEARANCE AS A NEW INDEX FOR IN VIVO CYTOCHROME P450 3A PHENOTYPING IN HUMANSTakashi Furuta, Atsushi Suzuki, Chieko Mori, Hiromi Shibasaki, Akitomo Yokokawa and Yasuji KasuyaDrug Metabolism and Disposition November 2003, 31 (11) 1283-1287; DOI: https://doi.org/10.1124/dmd.31.11.1283
Yu, Rosie Z.
- You have accessPHARMACOKINETICS OF A TUMOR NECROSIS FACTOR-α PHOSPHOROTHIOATE 2′-O-(2-METHOXYETHYL) MODIFIED ANTISENSE OLIGONUCLEOTIDE: COMPARISON ACROSS SPECIESRichard S. Geary, Rosie Z. Yu, Tanya Watanabe, Scott P. Henry, Greg E. Hardee, Alfred Chappell, John Matson, Henri Sasmor, Len Cummins and Arthur A. LevinDrug Metabolism and Disposition November 2003, 31 (11) 1419-1428; DOI: https://doi.org/10.1124/dmd.31.11.1419
Yu, Xiao
- You have accessBIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Charles C. Lin, Jonathan Z. Ho, Steven M. Pitzenberger, Maria V. Silva-Elipe, Christopher R. Gibson, Matthew P. Braun, Xiao Yu, James L. Yergey and Rominder SinghDrug Metabolism and Disposition November 2003, 31 (11) 1437-1447; DOI: https://doi.org/10.1124/dmd.31.11.1437
Z
Zhang, Jun
- You have accessINDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTORNathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315
Zhang, Qing-Yu
- You have accessCHARACTERIZATION OF MOUSE SMALL INTESTINAL CYTOCHROME P450 EXPRESSIONQing-Yu Zhang, Debbie Dunbar and Laurence S. KaminskyDrug Metabolism and Disposition November 2003, 31 (11) 1346-1351; DOI: https://doi.org/10.1124/dmd.31.11.1346
Zhang, Xiao-Xue
- You have accessINDUCTION OF MULTIDRUG RESISTANCE PROTEIN 3 (MRP3) IN VIVO IS INDEPENDENT OF CONSTITUTIVE ANDROSTANE RECEPTORNathan J. Cherrington, Angela L. Slitt, Jonathan M. Maher, Xiao-Xue Zhang, Jun Zhang, Wendong Huang, Yu-Jui Yvonne Wan, David D. Moore and Curtis D. KlaassenDrug Metabolism and Disposition November 2003, 31 (11) 1315-1319; DOI: https://doi.org/10.1124/dmd.31.11.1315